Global Seasonal Influenza Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 01-Mar-2019
No. of pages: 128
Inquire Before Buying

The global Seasonal Influenza Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Seasonal Influenza Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Seasonal Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Seasonal Influenza Vaccine in these regions.

This research report categorizes the global Seasonal Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Seasonal Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GSK

- Sinovac

- Changsheng

- CCBIO

- Aleph Biomedical

- Sanofi

- Lanzhou Institute Of Biological Product

- Siobp

- Hualan Bio

- Tianyuan Bio-Pharma

- Vaxtec

- Hissen

- Abbott

- Novartis

- Tasly&Jenner

- Tiantan

Market size by Product

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

- Other

Market size by End User

- Children

- Adults

- Elderly

- Pregnancy

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Seasonal Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Seasonal Influenza Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Seasonal Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Seasonal Influenza Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Seasonal Influenza Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Seasonal Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Seasonal Influenza Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Seasonal Influenza Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Product
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.4.4 Other
1.5 Market by End User
1.5.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by End User
1.5.2 Children
1.5.3 Adults
1.5.4 Elderly
1.5.5 Pregnancy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccine Market Size
2.1.1 Global Seasonal Influenza Vaccine Revenue 2014-2025
2.1.2 Global Seasonal Influenza Vaccine Sales 2014-2025
2.2 Seasonal Influenza Vaccine Growth Rate by Regions
2.2.1 Global Seasonal Influenza Vaccine Sales by Regions
2.2.2 Global Seasonal Influenza Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Seasonal Influenza Vaccine Sales by Manufacturers
3.1.1 Seasonal Influenza Vaccine Sales by Manufacturers
3.1.2 Seasonal Influenza Vaccine Sales Market Share by Manufacturers
3.1.3 Global Seasonal Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Seasonal Influenza Vaccine Revenue by Manufacturers
3.2.1 Seasonal Influenza Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Seasonal Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Seasonal Influenza Vaccine Price by Manufacturers
3.4 Seasonal Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Seasonal Influenza Vaccine Sales by Product
4.2 Global Seasonal Influenza Vaccine Revenue by Product
4.3 Seasonal Influenza Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Seasonal Influenza Vaccine Breakdown Data by End User
6 North America
6.1 North America Seasonal Influenza Vaccine by Countries
6.1.1 North America Seasonal Influenza Vaccine Sales by Countries
6.1.2 North America Seasonal Influenza Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Seasonal Influenza Vaccine by Product
6.3 North America Seasonal Influenza Vaccine by End User
7 Europe
7.1 Europe Seasonal Influenza Vaccine by Countries
7.1.1 Europe Seasonal Influenza Vaccine Sales by Countries
7.1.2 Europe Seasonal Influenza Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Seasonal Influenza Vaccine by Product
7.3 Europe Seasonal Influenza Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Seasonal Influenza Vaccine by Countries
8.1.1 Asia Pacific Seasonal Influenza Vaccine Sales by Countries
8.1.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Seasonal Influenza Vaccine by Product
8.3 Asia Pacific Seasonal Influenza Vaccine by End User
9 Central & South America
9.1 Central & South America Seasonal Influenza Vaccine by Countries
9.1.1 Central & South America Seasonal Influenza Vaccine Sales by Countries
9.1.2 Central & South America Seasonal Influenza Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Seasonal Influenza Vaccine by Product
9.3 Central & South America Seasonal Influenza Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Seasonal Influenza Vaccine by Countries
10.1.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Countries
10.1.2 Middle East and Africa Seasonal Influenza Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Seasonal Influenza Vaccine by Product
10.3 Middle East and Africa Seasonal Influenza Vaccine by End User
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Seasonal Influenza Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Sinovac
11.2.1 Sinovac Company Details
11.2.2 Company Business Overview
11.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sinovac Seasonal Influenza Vaccine Products Offered
11.2.5 Sinovac Recent Development
11.3 Changsheng
11.3.1 Changsheng Company Details
11.3.2 Company Business Overview
11.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Changsheng Seasonal Influenza Vaccine Products Offered
11.3.5 Changsheng Recent Development
11.4 CCBIO
11.4.1 CCBIO Company Details
11.4.2 Company Business Overview
11.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 CCBIO Seasonal Influenza Vaccine Products Offered
11.4.5 CCBIO Recent Development
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Company Details
11.5.2 Company Business Overview
11.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccine Products Offered
11.5.5 Aleph Biomedical Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sanofi Seasonal Influenza Vaccine Products Offered
11.6.5 Sanofi Recent Development
11.7 Lanzhou Institute Of Biological Product
11.7.1 Lanzhou Institute Of Biological Product Company Details
11.7.2 Company Business Overview
11.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Products Offered
11.7.5 Lanzhou Institute Of Biological Product Recent Development
11.8 Siobp
11.8.1 Siobp Company Details
11.8.2 Company Business Overview
11.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Siobp Seasonal Influenza Vaccine Products Offered
11.8.5 Siobp Recent Development
11.9 Hualan Bio
11.9.1 Hualan Bio Company Details
11.9.2 Company Business Overview
11.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Hualan Bio Seasonal Influenza Vaccine Products Offered
11.9.5 Hualan Bio Recent Development
11.10 Tianyuan Bio-Pharma
11.10.1 Tianyuan Bio-Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Products Offered
11.10.5 Tianyuan Bio-Pharma Recent Development
11.11 Vaxtec
11.12 Hissen
11.13 Abbott
11.14 Novartis
11.15 Tasly&Jenner
11.16 Tiantan
12 Future Forecast
12.1 Seasonal Influenza Vaccine Market Forecast by Regions
12.1.1 Global Seasonal Influenza Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Seasonal Influenza Vaccine Revenue Forecast by Regions 2019-2025
12.2 Seasonal Influenza Vaccine Market Forecast by Product
12.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Product 2019-2025
12.3 Seasonal Influenza Vaccine Market Forecast by End User
12.4 North America Seasonal Influenza Vaccine Forecast
12.5 Europe Seasonal Influenza Vaccine Forecast
12.6 Asia Pacific Seasonal Influenza Vaccine Forecast
12.7 Central & South America Seasonal Influenza Vaccine Forecast
12.8 Middle East and Africa Seasonal Influenza Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Seasonal Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Seasonal Influenza Vaccine Product Picture
Table Seasonal Influenza Vaccine Market Segments
Table Key Manufacturers Seasonal Influenza Vaccine Covered
Table Global Seasonal Influenza Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Seasonal Influenza Vaccine Sales Market Share by Product 2014-2025
Figure Trivalent Influenza Vaccine Product Picture
Table Major Manufacturers of Trivalent Influenza Vaccine
Figure Quadrivalent Influenza Vaccine Product Picture
Table Major Manufacturers of Quadrivalent Influenza Vaccine
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Seasonal Influenza Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Children
Figure Adults
Figure Elderly
Figure Pregnancy
Figure Seasonal Influenza Vaccine Report Years Considered
Figure Global Seasonal Influenza Vaccine Market Size 2014-2025 (Million US$)
Figure Global Seasonal Influenza Vaccine Sales 2014-2025 (K Doses)
Table Global Seasonal Influenza Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Seasonal Influenza Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Seasonal Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure Global Seasonal Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Seasonal Influenza Vaccine Sales Market Share by Regions
Table Global Seasonal Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Seasonal Influenza Vaccine Revenue Market Share by Regions
Table Global Seasonal Influenza Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Seasonal Influenza Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Seasonal Influenza Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Seasonal Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Seasonal Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Seasonal Influenza Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Seasonal Influenza Vaccine Price (2014-2019) (USD/Dose)
Table Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Seasonal Influenza Vaccine Product Type
Table Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Seasonal Influenza Vaccine Sales Share by Product (2014-2019)
Figure Global Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure Global Seasonal Influenza Vaccine Sales Market Share by Product in 2018
Table Global Seasonal Influenza Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Share by Product (2014-2019)
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Seasonal Influenza Vaccine Revenue Market Share by Product in 2018
Table Seasonal Influenza Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Seasonal Influenza Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Seasonal Influenza Vaccine Market Share by End User (2014-2019)
Figure Global Sales Seasonal Influenza Vaccine Market Share by End User in 2018
Figure North America Seasonal Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Seasonal Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Seasonal Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Seasonal Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Seasonal Influenza Vaccine Sales Market Share by Countries
Table North America Seasonal Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Seasonal Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure United States Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Seasonal Influenza Vaccine Market Share by Product
Table North America Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Seasonal Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Seasonal Influenza Vaccine Market Share by End User
Figure Europe Seasonal Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Seasonal Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Seasonal Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Seasonal Influenza Vaccine Sales Market Share by Countries
Table Europe Seasonal Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Seasonal Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure Germany Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Seasonal Influenza Vaccine Market Share by Product
Table Europe Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Seasonal Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Seasonal Influenza Vaccine Market Share by End User
Figure Asia Pacific Seasonal Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Seasonal Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Countries
Table Asia Pacific Seasonal Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure China Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Seasonal Influenza Vaccine Market Share by Product
Table Asia Pacific Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Seasonal Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Seasonal Influenza Vaccine Market Share by End User
Figure Central & South America Seasonal Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Seasonal Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Seasonal Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Seasonal Influenza Vaccine Sales Market Share by Countries
Table Central & South America Seasonal Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Seasonal Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure Brazil Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Seasonal Influenza Vaccine Market Share by Product
Table Central & South America Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Seasonal Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Seasonal Influenza Vaccine Market Share by End User
Figure Middle East and Africa Seasonal Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Seasonal Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Countries
Table Middle East and Africa Seasonal Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Countries
Figure GCC Countries Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Seasonal Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Seasonal Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Seasonal Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Seasonal Influenza Vaccine Market Share by Product
Table Middle East and Africa Seasonal Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Seasonal Influenza Vaccine Market Share by End User
Table GSK Company Details
Table GSK Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Sinovac Company Details
Table Sinovac Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sinovac Recent Development
Table Changsheng Company Details
Table Changsheng Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Changsheng Recent Development
Table CCBIO Company Details
Table CCBIO Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CCBIO Recent Development
Table Aleph Biomedical Company Details
Table Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Aleph Biomedical Recent Development
Table Sanofi Company Details
Table Sanofi Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Lanzhou Institute Of Biological Product Company Details
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lanzhou Institute Of Biological Product Recent Development
Table Siobp Company Details
Table Siobp Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Siobp Recent Development
Table Hualan Bio Company Details
Table Hualan Bio Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Hualan Bio Recent Development
Table Tianyuan Bio-Pharma Company Details
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Tianyuan Bio-Pharma Recent Development
Table Vaxtec Company Details
Table Hissen Company Details
Table Abbott Company Details
Table Novartis Company Details
Table Tasly&Jenner Company Details
Table Tiantan Company Details
Table Global Seasonal Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Seasonal Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Seasonal Influenza Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Seasonal Influenza Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Seasonal Influenza Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Seasonal Influenza Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Seasonal Influenza Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Seasonal Influenza Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Seasonal Influenza Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Seasonal Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Seasonal Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Seasonal Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Seasonal Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Seasonal Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Seasonal Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Seasonal Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Seasonal Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Seasonal Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Seasonal Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Seasonal Influenza Vaccine Value Chain
Table Seasonal Influenza Vaccine Customers List
Table Seasonal Influenza Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Dioscorea Polystachya Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 122
    Dioscorea Polystachya is a species of flowering plant in the yam family, which grows throughout East Asia yet native to C Scope of the Report: The worldwide market for Dioscorea Polystachya is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dioscorea Polystachya in global market, especially in North Americ......
  • Global Chinese Yam Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 123
    Chinese Yam is a species of flowering plant in the yam family, which grows throughout East Asia yet native to China. Scope of the Report: The worldwide market for Chinese Yam is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Chinese Yam in global market, especially in North America, Europe and Asia-Pacifi......
  • Global Cicada Shell Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 119
    Cicada Shell is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: The worldwide market for Cicada Shell is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cicada Shell in global market, especially in North America, Europe and Asia-Pacific, South America, M......
  • Global Cicada Slough Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 121
    Cicada Slough is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: The worldwide market for Cicada Slough is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cicada Slough in global market, especially in North America, Europe and Asia-Pacific, South America......
  • Global Periostracum Cicadae Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 115
    Periostracum Cicadae is the skin that has been removed from Cicada, which has medicinal value. Scope of the Report: The worldwide market for Periostracum Cicadae is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Periostracum Cicadae in global market, especially in North America, Europe and Asia-Pacific, S......
  • Global Ganoderma Lucidum Power Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 121
    Ganoderma lucidum, commonly known as the lingzi mushroom, is frequently used in traditional Chinese medicine. Its popularity extends to Japanese and Korean medicine, and it has been making its way west. Ganoderma lucidum has anti-oxidative effects when supplemented. It also has a therapeutic effect on insulin resistance, reduces the risk of prostate cancer, and can help treat a variety of conditions associated with metabolic syndrome. The lingzi mushroom is well kno......
  • Global Insulin Like Growth Factor I Market Research Report 2012-2024
    Published: 16-Jun-2019        Price: US 1800 Onwards        Pages: 69
    Summary The global Insulin Like Growth Factor I market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products ment......
  • Global Fibrinogen Market Research Report 2012-2024
    Published: 14-Jun-2019        Price: US 1800 Onwards        Pages: 71
    Summary The global Fibrinogen market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global (United States, European Union and China) Proton Pump Inhibitor Drug Market Research Report 2019-2025
    Published: 14-Jun-2019        Price: US 3280 Onwards        Pages: 116
    In 2019, the market size of Proton Pump Inhibitor Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Proton Pump Inhibitor Drug. This report studies the global......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs